title: Protection afforded by maltosyl-beta-cyclodextrin against alpha-chymotrypsin-catalyzed hydrolysis of a luteinizing hormone-releasing hormone agonist, buserelin acetate.
abstract: OBJECTIVE
  The present study addresses how maltosyl-beta-cyclodextrin (G2-beta-CyD) impacts upon the alpha-chymotrypsin-catalyzed hydrolysis of buserelin acetate, an agonist of luteinizing hormone-releasing hormone with emphasis upon the direct effect of G2-beta-CyD on the activity of the protease.
  
  
  METHODS
  Kinetic and solubility studies were performed in isotonic phosphate buffer (pH 7.4) at 25 degrees C and 37 degrees C. The interaction of alpha-chymotrypsin with G2-beta-CyD in the buffer solution was examined by differential scanning calorimetry.
  
  
  RESULTS
  G2-beta-CyD decelerated the alpha-chymotrypsin-catalyzed hydrolysis of buserelin acetate to give the 1-3 tripeptide and the 4-9 hexapeptide fragments. This deceleration can be explained solely by a non-productive encounter between a complex of the substrate with G2-beta-CyD and the protease at relatively low CyD concentrations, while the direct inhibitory effect of G2-beta-CyD on the proteolytic activity made a considerable contribution to the overall deceleration of the hydrolysis at higher CyD concentrations. Calorimetric studies indicate the presence of intermediate states in the thermal unfolding of alpha-chymotrypsin, simultaneously accompanied by the autolysis. By contrast, a two-state thermal unfolding of alpha-chymotrypsin was observed in the presence of G2-beta-CyD, suggesting reduced proteolytic activity upon binding to G2-beta-CyD.
  
  
  CONCLUSIONS
  These results suggest that G2-beta-CyD at higher concentrations inhibits the proteolytic action of alpha-chymotrypsin through direct interaction with the protease, as well as through the formation of a non-productive complex with the substrate.
authors.affiliation: Pharma Research Laboratories, Hoechist Japan Ltd., Saitama, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Matsubara
authors.forename: Y
authors.initials: Y
authors.lastname: Ando
authors.forename: T
authors.initials: T
authors.lastname: Irie
authors.forename: K
authors.initials: K
authors.lastname: Uekama
mesh_terms: D002064:Buserelin / Q000737:chemistry / Q000378:metabolism*; D002152:Calorimetry, Differential Scanning; D002384:Catalysis; D002851:Chromatography, High Pressure Liquid; D002918:Chymotrypsin / Q000037:antagonists & inhibitors* / Q000737:chemistry; D003505:Cyclodextrins / Q000737:chemistry / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000378:metabolism*; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006868:Hydrolysis; D007700:Kinetics; D011489:Protein Denaturation; D047392:beta-Cyclodextrins
chemical_list: D003505:Cyclodextrins; D004791:Enzyme Inhibitors; D047392:beta-Cyclodextrins; C075170:6-O-maltosyl-beta-cyclodextrin; D007987:Gonadotropin-Releasing Hormone; D002918:Chymotrypsin; D002064:Buserelin